Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of R A Rifkind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R A Rifkind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R A Rifkind more than expected).
This network shows the impact of papers produced by R A Rifkind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R A Rifkind. The network helps show where R A Rifkind may publish in the future.
Co-authorship network of co-authors of R A Rifkind
This figure shows the co-authorship network connecting the top 25 collaborators of R A Rifkind.
A scholar is included among the top collaborators of R A Rifkind based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with R A Rifkind. R A Rifkind is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Richon, Victoria M., Robert G. Ramsay, R A Rifkind, & P A Marks. (1989). Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.. PubMed. 4(2). 165–73.45 indexed citations
9.
Rifkind, R A, et al.. (1987). Induced erythroleukemia differentiation: cellular and molecular aspects.. PubMed. 13(1-2). 277–84.9 indexed citations
10.
Marks, P A, Robert G. Ramsay, M Sheffery, & R A Rifkind. (1987). Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.. PubMed. 251. 253–68.2 indexed citations
11.
Leyland-Jones, B, Daniel F. Hoth, D. Matthew Shoemaker, et al.. (1986). Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.. PubMed. 70(8). 991–6.22 indexed citations
12.
Murate, Takashi, et al.. (1984). Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.. PubMed. 37. 327–40.9 indexed citations
Marks, P A, et al.. (1978). Erythroid cell differentiation. Molecular and Cellular Biochemistry. 21(1). 33–41.9 indexed citations
18.
Rifkind, R A & P A Marks. (1978). Regulation of differentiation in transformed erythroid cells.. PubMed. 4(1-2). 189–206.5 indexed citations
19.
Fibach, Eitan, Hiroshi Yamasaki, Weinstein Ib, P A Marks, & R A Rifkind. (1978). Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation.. PubMed. 38(11 Pt 1). 3685–8.48 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.